The 7,909-nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer, has been determined and used to deduce the corresponding genome 10) , from cervical carcinomas has further stimulated research in this field. These viruses were discovered in more than 70% of the malignant genital tumors examined, and in many others HPV-16-related sequences were detected (3, 32). Among these is HPV-33, which was recently cloned from an invasive cervical carcinoma, using HPV-16 as a probe under conditions of reduced stringency (S. Beaudenon, D. Kremsdorf, 0. Croissant, S. Jablonska, S. Wain-Hobson, and G. Orth, Nature (London), in press). In the present study we have determined the DNA sequence of an episomal form of HPV-33 and describe its relationship to HPV-16. * The complete 7,909-nucleotide sequence of HPV-33, determined by the M13 shotgun cloning/dideoxy sequencing approach, is presented in Fig. 1 . On average, each position was sequenced 6.5 times and 92% of the sequence was obtained from both strands. In agreement with the convention for other papillomavirus sequences, the numbering begins at a site resembling the recognition sequence for HpaI in the noncoding region.
The 7,909-nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer, has been determined and used to deduce the corresponding genome arrangement. Extensive sequence homologies and other genetic features are shared with the related oncogenic virus, human papillomavirus type 16 , especially in the major reading frames. A surprising difference was found in the noncoding region of human papiUlomavirus type 33 as, unlike all other sequenced papillomaviruses, it contains a perfect 78-base pair tandem repeat.
Papillomaviruses are members of the papovavirus family and possess a genome of about 7,900 base pairs (bp) consisting of a covalently closed circular DNA molecule. Human papillomaviruses (HPV) are classified on the basis of their DNA sequence homology (6) and nearly 40 types have now been described. Considerable insight into HPV biology and their involvement in human disease has been attained by the application of the techniques of molecular biology. A possible role for HPVs in human cancer had been suspected for several years and was further supported by the frequent detection of HPV DNA in tumors resulting from the malignant conversion of cutaneous lesions (17) and genital warts (32) . The cloning of two HPV genomes, HPV-16 and HPV-18 (3, 10) , from cervical carcinomas has further stimulated research in this field. These viruses were discovered in more than 70% of the malignant genital tumors examined, and in many others HPV-16-related sequences were detected (3, 32) . Among these is HPV-33, which was recently cloned from an invasive cervical carcinoma, using HPV-16 as a probe under conditions of reduced stringency (S. Beaudenon, D. Kremsdorf, 0. Croissant, S. Jablonska, S. Wain-Hobson, and G. Orth, Nature (London), in press). In the present study we have determined the DNA sequence of an episomal form of HPV-33 and describe its relationship to HPV-16. * The complete 7,909-nucleotide sequence of HPV-33, determined by the M13 shotgun cloning/dideoxy sequencing approach, is presented in Fig. 1 (Fig. 2) . Some features common to HPV-33 and HPV types la, 6b, and 16 together with the cottontail rabbit papillomavirus and bovine papillomavirus type 1, BPV-1 (5, 7, 8, 12, 20, 21) within the E1/E2 overlap and, as both reading frames are unaffected, the possibility of clustered BgIII sites can be excluded. Another property common to all papillomaviruses, except BPV-1, is the overlap between the Li and L2 reading frames. Following Li is the 892-bp noncoding region which, by analogy with BPV-1 (14, 28) , undoubtedly contains the origin of replication and various transcriptional regulatory elements. The principal characteristics of the HPV-33 genome are summarized in Table 1. HPV-16 is the only other oncogehic papillomavirus, isolated from tumors of the anogenital region, which has been completely sequenced (21) . The When the open reading frames were compared pairwise (Table 2) , it was found that El, E2, E6, E7, Li, and L2 displayed between 65 and 75% homology, whereas those for E4 and E5 were more divergent (about 50% homology). These findings confirm the heteroduplex analysis performed previously (Beaudenon et al., in press). A comparative study (7) of papillomavirus El gene products showed that the polypeptide consists of an NH2-terminal segment, the sequence of which is highly variable, and a COOH-terminal domain of well-conserved primary structure. The longest Fig. 1 ) is found near the 5' end of the El reading frame in a region encoding the variable domain of the polypeptide. Several other regions of complete identity (19 to 28 nucleotides) were detected elsewhere in El, and also in E2, L2, and Li. As many of these sequences are not found in the genomes of other HPVs, such as HPV-la and HPV-6b, this raises the possibility that the corresponding oligonucleotides could be produced and used as diagnostic hybridization probes for screening biopsy material from potentially tumorigenic lesions.
The papillomavirus gene products may be divided into those believed to play a purely structural role, Li and L2, and those required for viral propagation and persistence. The results of a comparison of the probable products of the major reading frames from HPV-33, -16, and -6b are summarized in Table 2 . As expected, there is strong identity between the oncogenic HPV-33 and -16, particularly for the proposed El, E6, E7, L2, and Li proteins. When conservative substitutions are included the homology between the two Li polypeptides increases to 90%, suggesting that the corresponding capsids must be antigenically related. In contrast, significantly weaker homologies were detected when the analysis was extended to include the benign genital wart-forming HPV-6b ( Table 2) . Comparison of the HPV-16 proteins with those of HPV-6b revealed slightly more homology than was found with HPV-33, suggesting a closer evolutionary relationship.
The noncoding region of HPV-33 displays several unique properties and bears only weak resemblance to its homolog in HPV-16. Shortly after the Li stop codon is a 223-bp stretch of DNA (positions 7097 to 7320, Fig. 1 ) which is unusually rich in thymine plus guanine (79%) and includes the putative polyadenylation signal for the late transcripts. Contained within this segment of the noncoding region are two copies of a 19-bp direct repeat (with one mismatch) and seven copies of the motif TTGTRTR (where R is A or G). The latter is also found seven times in the corresponding region of HPV-16, suggesting that it may represent a recognition site for proteins involved in replication. It should be noted that nascent replication forks have been localized in this region of the BPV-1 genome (28) and that the origin of replication of the Epstein-Barr virus consists of a family of repeated sequences (31) .
A 12-bp palindrome (ACCG... .CGGT) that occurs exclusively in the noncoding region of all papillomavirus genomes examined was recently reported by Dartmann et al. (K. Dartmann, E. Schwarz, L. Gissmann, and H. Zur Hausen, Virology, in press). Three copies were found in the HPV-33 genome (Fig. 3) and these occupy the same positions in the noncoding region of HPV-16. A role for the palindrome as a possible control site for the early promoter was proposed (4, 14; Dartmann et al., in press), and indirect support is provided by our finding that the noncoding regions of HPVs, such as HPV-33, do not display the clustered arrangement of recognition sites for the promoter-specific activation factor Spl (11). This is in direct contrast to the situation in another papovavirus, simian virus 40 (SV40) (11, 13) .
The most striking feature of HPV-33 is a perfect 78-bp tandem repeat located 200 bp after the putative origin of replication (Fig. 3) . No other repeats of this size or sequence have been described in the genomes of other papillomaviruses. The presumed early promoter for HPV-33 is located about 300 bp downstream from the tandem repeat, and the characteristic promoter elements (4) could be iden- (15) after sonication of p15-5, essentially as described previously (27) . DNA sequencing was performed by the modified dideoxy chain termination method (2, 18, 19) . A small part of the noncoding region was found to be absent or underrepresented in the M13 library (>300 clones), and its sequence was obtained directly from p15-5 by the method of Smith (23) . Briefly, restriction fragments isolated from 2 "complementary" M13 clones were used to prime DNA synthesis on templates prepared from p15-5 which had been linearized with a restriction enzyme and then treated with exonuclease III (200 U/pmol of DNA for 1 h at 22°C). DNA sequences were compiled and analysed with the programs of Staden (25, 26 tified (Fig. 3) . The size, position, and arrangement of the 78-bp repeats in the HPV-33 genome suggest that they may function as enhancers of viral transcription. Tandem repeats of 72, 73, and 68 bp have been located near the early promoter of SV40 (1, 4, 13) , in the long terminal repeat of Moloney murine sarcoma virus (9) , and in the BK virus genome (22) and shown to enhance transcription from PolIIdependent promoters in a cis-active manner. From mutagenesis of the SV40 enhancer (13, 29) and sequence comparisons of characterized transcriptional activators, a consensus enhancer sequence was derived. This structure could not be detected in the 78-bp repeat, but a potential Z-DNA-forming region was uncovered. Z-DNA is believed to attract regulatory molecules to eucaryotic promoters and a Z-DNA antibody-binding site has been demonstrated within the SV40 enhancer (16) . The sequence to which this antibody binds is also found, albeit with a single mismatch, in the putative HPV-33 enhancer (positions 7520 to 7527 and 7599 to 7606, Fig. 1 and 3) .
The proposed HPV-33 enhancer shows no extended sequence homology to the well-characterized enhancers or to other papillomavirus regulatory regions. However, it has recently been demonstrated that an enhancer-like element is located in the noncoding region of BPV-1 and that it requires the E2 product for activation (24) . These findings support our proposal that the 78-bp tandem repeats could have enhancer function and may indicate that the relatively low homology (Table 2 ) between the E2 proteins of HPV-33 and -16 reflects a specificity for the corresponding enhancer/ regulatory regions. Experiments are currently in progress to substantiate some of these possibilities.
